Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296543 · ClinicalTrials.gov registry record
T Wave Alternans in Hemodialysis
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 30
- Enrollment target
NCT00296543: Completed study, sponsored by Indiana University.
NCT00296543 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00296543 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-08 |
What the finished NCT00296543 record still lists
NCT00296543 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00296543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00296543 about?
NCT00296543 is a clinical study titled "T Wave Alternans in Hemodialysis". The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.
What is the current status of trial NCT00296543?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-10. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00296543?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia